Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Eagle Pharmaceuticals Inc...

    OTC: EGRX · Real-Time Price · USD
    1.25
    -0.25 (-16.67%)
    At close: Apr 04, 2025, 3:30 PM

    Eagle Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 55.32M 97.66M
    Short-Term Investments
    		 n/a 4.98M
    Long-Term Investments
    		 10.01M 6.03M
    Other Long-Term Assets
    		 15.72M 4.25M
    Receivables
    		 73.44M 41.15M
    Inventory
    		 47.79M 21.91M
    Other Current Assets
    		 3.26M 5.64M
    Total Current Assets
    		 188.75M 172.61M
    Property-Plant & Equipment
    		 1.17M 1.64M
    Goodwill & Intangibles
    		 163.36M 50.41M
    Total Long-Term Assets
    		 217.41M 81.13M
    Total Assets
    		 406.16M 253.73M
    Account Payables
    		 18.99M 16.43M
    Deferred Revenue
    		 n/a 25.36M
    Short-Term Debt
    		 6.25M 25.61M
    Other Current Liabilities
    		 10.84M 6.18M
    Total Current Liabilities
    		 111.09M 74.38M
    Long-Term Debt
    		 56.22M n/a
    Other Long-Term Liabilities
    		 1.51M -1K
    Total Long-Term Liabilities
    		 61.51M 2.9M
    Total Liabilities
    		 172.6M 77.28M
    Total Debt
    		 67.79M 25.61M
    Common Stock
    		 18K 17K
    Retained Earnings
    		 111.5M 75.86M
    Comprehensive Income
    		 -1.11M -94K
    Shareholders Equity
    		 233.56M 176.45M
    Total Investments
    		 10.01M 4.98M

    Add to Watchlist